2004
DOI: 10.1002/pds.1042
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of an antibiotic intravenous to oral sequential therapy program

Abstract: Focusing on quinolones, the implementation of a sequential therapy program based on promoting an early switch from intravenous to oral regimen has proved its capacity to alter the utilisation profile of these antibiotics. The program has permitted the hospital a global saving of 41420 dollars for these drugs during the period of time considered.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0
3

Year Published

2005
2005
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 12 publications
1
8
0
3
Order By: Relevance
“…34 Where details of the strategies used to achieve this were given, one-third of Trusts had restricted iv ciprofloxacin and advocated early switch to the much cheaper oral form. This is a welldescribed intervention: [35][36][37] the high bioavailability of oral ciprofloxacin may give pharmacists confidence in making this switch, and therefore makes a good target for an initial antimicrobial intervention in Trusts where there had previously been little activity in this area. However, such savings cannot be assumed to be recurrent; in Trusts where specialist staff have been employed in Pharmacy for some time, cost savings may be high initially, and then tail off as the 'easy targets' are exhausted.…”
Section: Discussionmentioning
confidence: 99%
“…34 Where details of the strategies used to achieve this were given, one-third of Trusts had restricted iv ciprofloxacin and advocated early switch to the much cheaper oral form. This is a welldescribed intervention: [35][36][37] the high bioavailability of oral ciprofloxacin may give pharmacists confidence in making this switch, and therefore makes a good target for an initial antimicrobial intervention in Trusts where there had previously been little activity in this area. However, such savings cannot be assumed to be recurrent; in Trusts where specialist staff have been employed in Pharmacy for some time, cost savings may be high initially, and then tail off as the 'easy targets' are exhausted.…”
Section: Discussionmentioning
confidence: 99%
“…Alternatively, there are some oral antibiotics that have a high bioavailability, thus the equivalent IV formulation appears costly to use with no extra clinical benefit. Sequential therapy programmes have been undertaken with quinolones for this reason showing that significant cost savings can be made by reducing the usage of IV formulations by 60% . In this study, the IV route was reserved only for the seriously ill or those with intestinal diseases that prevented sufficient oral absorption.…”
Section: Introductionmentioning
confidence: 99%
“…The over 20 times more expensive intravenous therapy means a considerable additional economic burden for the department without increasing effectivity. A series of other clinical studies has shown that changing antibiotic therapy from intravenous to oral administration considerably lowers the costs for this drug therapy with the same treatment success [10,21].…”
Section: Discussionmentioning
confidence: 99%